Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| 1 |
Apple
AAPL
|
+$3.33B |
| 2 |
NVIDIA
NVDA
|
+$1.99B |
| 3 |
Visa
V
|
+$1.04B |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.04B |
| 5 |
Amazon
AMZN
|
+$964M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.52B |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$1.07B |
| 4 |
iShares MSCI India ETF
INDA
|
+$871M |
| 5 |
CrowdStrike
CRWD
|
+$796M |
Sector Composition
| 1 | Technology | 21.76% |
| 2 | Consumer Discretionary | 9.86% |
| 3 | Financials | 9.03% |
| 4 | Healthcare | 6.97% |
| 5 | Industrials | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4201
Build-A-Bear
BBW
$959M
| $638K | ﹤0.01% |
25,231
+16,353
| +184% | +$413K |
|
4202
Direxion Daily NVDA Bear 1X Shares
NVDD
$29.5M
| $637K | ﹤0.01% |
80,431
+42,157
| +110% | +$334K |
|
4203
Funko
FNKO
$189M
| $637K | ﹤0.01% |
65,259
+40,487
| +163% | +$395K |
|
4204
Cato Corp
CATO
$86.4M
| $635K | ﹤0.01% |
114,650
+99,527
| +658% | +$551K |
|
4205
LoveSac
LOVE
$261M
| $635K | ﹤0.01% |
+28,125
| New | +$635K |
|
4206
ProFrac Holding
ACDC
$649M
| $635K | ﹤0.01% |
85,658
+30,498
| +55% | +$226K |
|
4207
Clean Energy Fuels
CLNE
$581M
| $635K | ﹤0.01% |
237,682
+61,263
| +35% | +$164K |
|
4208
Univest Financial
UVSP
$899M
| $634K | ﹤0.01% |
+27,752
| New | +$634K |
|
4209
Invesco Alerian Galaxy Blockchain Users and Decentralized Commerce ETF
BLKC
$7.08M
| $634K | ﹤0.01% |
30,185
+5,122
| +20% | +$108K |
|
4210
Avantis Emerging Markets Small Cap Equity ETF
AVEE
$55.5M
| $632K | ﹤0.01% |
11,410
-3,333
| -23% | -$185K |
|
4211
FT Vest US Equity Deep Buffer ETF August
DAUG
$353M
| $632K | ﹤0.01% |
16,699
-37,345
| -69% | -$1.41M |
|
4212
Hawaiian Electric Industries
HE
$2.04B
| $632K | ﹤0.01% |
70,017
-510,421
| -88% | -$4.6M |
|
4213
LSB Industries
LXU
$593M
| $631K | ﹤0.01% |
77,192
+51,622
| +202% | +$422K |
|
4214
Aurora
AUR
$11.2B
| $631K | ﹤0.01% |
227,880
-19,911
| -8% | -$55.2K |
|
4215
Avantis Core Municipal Fixed Income ETF
AVMU
$151M
| $631K | ﹤0.01% |
13,673
-19,119
| -58% | -$882K |
|
4216
Bit Digital
BTBT
$1B
| $631K | ﹤0.01% |
198,347
+50,557
| +34% | +$161K |
|
4217
FT Vest US Equity Buffer ETF July
FJUL
$1.05B
| $630K | ﹤0.01% |
13,680
-45,201
| -77% | -$2.08M |
|
4218
SPDR S&P Emerging Markets Dividend ETF
EDIV
$896M
| $630K | ﹤0.01% |
17,849
-209,069
| -92% | -$7.38M |
|
4219
Calvert Ultra-Short Investment Grade ETF
CVSB
$179M
| $629K | ﹤0.01% |
12,487
-21,508
| -63% | -$1.08M |
|
4220
FlexShares Real Assets Allocation Index Fund
ASET
$7.53M
| $629K | ﹤0.01% |
20,859
-735
| -3% | -$22.2K |
|
4221
Invesco AI and Next Gen Software ETF
IGPT
$562M
| $629K | ﹤0.01% |
13,244
-55,074
| -81% | -$2.62M |
|
|
HLVX
4222
DELISTED
HilleVax
HLVX
| $629K | ﹤0.01% |
43,493
+11,877
| +38% | +$172K |
|
4223
Arbutus Biopharma
ABUS
$815M
| $629K | ﹤0.01% |
203,398
+159,279
| +361% | +$492K |
|
4224
Cambria Cannabis ETF
TOKE
$16.4M
| $627K | ﹤0.01% |
110,122
+73,490
| +201% | +$418K |
|
4225
Vanda Pharmaceuticals
VNDA
$265M
| $627K | ﹤0.01% |
110,896
+48,992
| +79% | +$277K |
|